New pill aims to shorten COPD Flare-Ups from common cold
NCT ID NCT07610395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an oral drug called vapendavir in 180 adults with COPD who catch a rhinovirus (common cold). The goal is to see if it can reduce the severity and length of breathing symptoms compared to a placebo. Participants are randomly assigned to one of two doses or a placebo, and they report their symptoms daily.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vapendavir
What this could lead to
If it works, this could point toward a treatment that reduces the severity and duration of cold-related breathing problems in people with COPD.
What could go wrong
This is an early phase 2 trial with only 180 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AMR Clinical - Tempe
RECRUITINGTempe, Arizona, 85281, United States
Contact
-
Accelerated Clinical Trials, LLC
RECRUITINGSnellville, Georgia, 30078, United States
Contact
-
Apex Clinical Research
RECRUITINGSan Diego, California, 92120, United States
Contact
-
Brooklyn Clinical Research
RECRUITINGBrooklyn, New York, 11226, United States
Contact
-
CRC Kings Mountain
RECRUITINGKings Mountain, North Carolina, 28086, United States
Contact
-
Clinical Research Associates of Central PA, LLC
RECRUITINGDuBois, Pennsylvania, 15801, United States
Contact
-
Clinical Research of Rock Hill
RECRUITINGRock Hill, South Carolina, 29732, United States
Contact
-
NewportNativeMD, Inc.
RECRUITINGNewport Beach, California, 92663, United States
Contact
-
Patient First Clinical Trials (PFCTRIALS)
RECRUITINGLutherville, Maryland, 21093, United States
Contact
-
Preferred Primary Care Physicians - St. Clair
RECRUITINGPittsburgh, Pennsylvania, 15423, United States
Contact
-
Remington-Davis, Inc.
RECRUITINGColumbus, Ohio, 43215, United States
Contact
-
VM Clintrials
RECRUITINGMiami Lakes, Florida, 33014, United States
Contact
-
Velocity Clinical Research - Anderson
RECRUITINGAnderson, South Carolina, 29621, United States
Contact
-
Velocity Clinical Research - Valparaiso
RECRUITINGValparaiso, Indiana, 46383, United States
Contact